SCHEMBL997454

SCHEMBL997454

CCc1cnc(-c2ccc(C)cc2N)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.37
THRB P10828 2/20 0.37
ALOX15 P16050 2/20 0.37
CYP3A4 P08684 2/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
ALDH1A1 P00352 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
MAPT P10636 3/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 2/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B13 Q7Z5P4 2/20 0.33
CA1 P00915 1/20 0.33
GRM5 P41594 1/20 0.33
ICAM1 P05362 2/20 0.33
SELE P16581 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL996771 0.80 FEN1 (0.41) ALDH1A1L3MBTL1MAPTHSD17B10RAB9A
SCHEMBL996294 0.77 TSHR (0.44) CYP3A4SMN1; SMN2ALDH1A1L3MBTL1MAPT
SCHEMBL10141022 0.75 CYP11B1 (0.48) TDP1TP53SMN1; SMN2CYP11B1CYP11B2
SCHEMBL11698155 0.74 CDC7 (0.59) TP53SMN1; SMN2ALDH1A1MAPTHSD17B10
SCHEMBL11698160 0.73 SMN1; SMN2 (0.48) TDP1THRBALOX15CYP3A4TP53
SCHEMBL16735817 0.73 GSK3B (0.41) ALOX15SMN1; SMN2ALDH1A1HSD17B10POLB
SCHEMBL2093617 0.72 L3MBTL1 (0.41) TP53SMN1; SMN2CYP11B1CYP11B2ALDH1A1
SCHEMBL26759056 0.70 HDAC1 (0.41) TP53SMN1; SMN2CYP11B1CYP11B2ALDH1A1
SCHEMBL996557 0.70 SREBF2 (0.43) TDP1THRBALOX15CYP3A4TP53
SCHEMBL18015904 0.69 MAPT (0.39) TDP1ALOX15ALDH1A1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919898-B1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS TIBOTEC PHARM LTD (IE) 2011-01-26 EP disclosed
EP-1919898-B1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS TIBOTEC PHARM LTD (IE) 2011-01-26 EP disclosed
US-7666834-B2 Macrocyclic inhibitors of hepatitis C virus TIBOTEC PHARMACEUTICALS LTD. (IE) 2010-02-23 US disclosed
US-7666834-B2 Macrocyclic inhibitors of hepatitis C virus TIBOTEC PHARMACEUTICALS LTD. (IE) 2010-02-23 US disclosed
US-7666834-B2 Macrocyclic inhibitors of hepatitis C virus TIBOTEC PHARMACEUTICALS LTD. (IE) 2010-02-23 US disclosed
US-20090105302-A1 Macrocylic Inhibitors of Hepatitis C Virus JANSSEN SCIENCES IRELAND UC (IE) 2009-04-23 US disclosed
US-20090105302-A1 Macrocylic Inhibitors of Hepatitis C Virus JANSSEN SCIENCES IRELAND UC (IE) 2009-04-23 US disclosed
US-20090105302-A1 Macrocylic Inhibitors of Hepatitis C Virus JANSSEN SCIENCES IRELAND UC (IE) 2009-04-23 US disclosed
CN-101273027-A Macrocyclic inhibitors of hepatitis C virus TIBOTEC PHARM LTD (IE) 2008-09-24 CN disclosed
EP-1919898-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS Tibotec Pharmaceuticals Ltd. (IE) 2008-05-14 EP disclosed
WO-2007014922-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS TIBOTEC PHARMACEUTICALS LTD. (IE) 2007-02-08 WO disclosed
WO-2007014922-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS TIBOTEC PHARMACEUTICALS LTD. (IE) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105302-A1 Macrocylic Inhibitors of Hepatitis C Virus HCCS, CBR1, CYP2B6 TDP1 4562/4885THRB 2694/4885ALOX15 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.